Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 20, 2025 07:53 ET | Source: Research and Markets

Diabetes Drugs Market Trends, Opportunity, and Forecasts, 2024-2030: Launch of Novel Drug Classes like GLP-1 Receptor Agonists, SGLT2 Inhibitors, and DPP-4 Inhibitors Transforming the Landscape

Dublin, Feb. 20, 2025 (GLOBE NEWSWIRE) -- The "Diabetes Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ResearchAndMarkets.com's...
December 05, 2024 10:28 ET | Source: Research and Markets

Growth Trends in the Insulin Biosimilar Market, Forecast to 2034

Dublin, Dec. 05, 2024 (GLOBE NEWSWIRE) -- The "Insulin Biosimilar Market by Type of Insulin, by Mode of Administration, by Therapeutic Application, by Distribution Channel, and by Region" report has...
January 30, 2024 19:57 ET | Source: Research and Markets

China Diabetes Care Drugs Market to Reach USD 13.73 Billion by 2028, Propelled by Rising Prevalence and Advanced Treatment Options

Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "China Diabetes Care Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)" report has been added to ...
January 29, 2024 12:24 ET | Source: Research and Markets

Biosimilar Insulin Market Global Industry Analysis - Market Set to Surge, Spearheaded by High Demand in APAC and Cost-Effective Innovations

Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Biosimilar Insulin Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application,...
July 14, 2022 09:00 ET | Source: Persistence Market Research

Biosimilar Insulin Market to exhibit high growth over the coming years a value CAGR of 14.9% by the end of 2032 – Persistence Market Research

New York, July 14, 2022 (GLOBE NEWSWIRE) -- The biosimilar insulin market reached US$ 1.3 Bn at the end of 2021 and is expected to surge ahead at a CAGR of 14.9% over the forecast period...
August 27, 2021 06:13 ET | Source: Research and Markets

United States $46 Billion Biosimilar Insulin Market Opportunity & Clinical Trials Forecasts to 2026

Dublin, Aug. 27, 2021 (GLOBE NEWSWIRE) -- The "US Biosimilar Insulin Market Opportunity & Clinical Trials Insight 2026" report has been added to ResearchAndMarkets.com's offering. The US...
July 22, 2021 07:38 ET | Source: Research and Markets

Insights on the Rapid Acting Insulin Global Market to 2027 - by Product Type, Indication, Distribution Channel and Regional Outlook

Dublin, July 22, 2021 (GLOBE NEWSWIRE) -- The "Global Rapid Acting Insulin Market By Product Type, By Indication, By Distribution Channel, By Regional Outlook, Industry Analysis Report and Forecast,...
April 23, 2021 06:53 ET | Source: Research and Markets

China Recombinant Lispro Insulin Markets, 2016-2020 & 2021-2025

Dublin, April 23, 2021 (GLOBE NEWSWIRE) -- The "Investigation Report on China's Recombinant Lispro Insulin Market, 2021-2025" report has been added to ResearchAndMarkets.com's offering. By the end...